Class information for:
Level 1: AT 211//TARGETED ALPHA THERAPY//BI 213

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
11217 933 31.2 66%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
701 12232 RADIOIMMUNOTHERAPY//BISPECIFIC ANTIBODIES//EP CAM

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 AT 211 Author keyword 72 81% 5% 43
2 TARGETED ALPHA THERAPY Author keyword 59 84% 3% 32
3 BI 213 Author keyword 49 79% 3% 31
4 ASTATINE Author keyword 48 74% 4% 35
5 ASTATINE 211 Author keyword 46 76% 3% 32
6 ACTINIUM 225 Author keyword 34 93% 1% 13
7 BISMUTH 213 Author keyword 33 100% 1% 13
8 AC 225 Author keyword 29 72% 2% 23
9 ALPHA EMITTER BI 213 Author keyword 23 100% 1% 10
10 RADIOIMMUNOTHERAPY Author keyword 22 13% 17% 157

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 AT 211 72 81% 5% 43 Search AT+211 Search AT+211
2 TARGETED ALPHA THERAPY 59 84% 3% 32 Search TARGETED+ALPHA+THERAPY Search TARGETED+ALPHA+THERAPY
3 BI 213 49 79% 3% 31 Search BI+213 Search BI+213
4 ASTATINE 48 74% 4% 35 Search ASTATINE Search ASTATINE
5 ASTATINE 211 46 76% 3% 32 Search ASTATINE+211 Search ASTATINE+211
6 ACTINIUM 225 34 93% 1% 13 Search ACTINIUM+225 Search ACTINIUM+225
7 BISMUTH 213 33 100% 1% 13 Search BISMUTH+213 Search BISMUTH+213
8 AC 225 29 72% 2% 23 Search AC+225 Search AC+225
9 ALPHA EMITTER BI 213 23 100% 1% 10 Search ALPHA+EMITTER+BI+213 Search ALPHA+EMITTER+BI+213
10 RADIOIMMUNOTHERAPY 22 13% 17% 157 Search RADIOIMMUNOTHERAPY Search RADIOIMMUNOTHERAPY

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ASTATINE 211 95 82% 6% 55
2 BI 213 90 88% 5% 43
3 AT 211 86 84% 5% 47
4 RADIOIMMUNOTHERAPY 36 14% 26% 244
5 VASCULAR TARGETED RADIOIMMUNOTHERAPY 31 92% 1% 12
6 BI 212 30 100% 1% 12
7 AC 225 29 72% 2% 23
8 DISSEMINATED PERITONEAL DISEASE 29 72% 2% 23
9 ASTATINE 15 73% 1% 11
10 PARTICLE EMITTER 14 100% 1% 7

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Radioimmunotherapy with alpha-emitting nuclides 1998 191 41 73%
Cancer radioimmunotherapy with alpha-emitting nuclides 2005 76 121 72%
Realizing the potential of the Actinium-225 radionuclide generator in targeted alpha particle therapy applications 2008 32 50 72%
Astatine-211-labeled radiotherapeutics: An emerging approach to targeted alpha-particle radiotherapy 2000 98 73 71%
Radioimmunotherapy with a- particle- emitting radionuclides 2014 2 149 83%
Alpha-particles for targeted therapy 2008 27 18 72%
Radioimmunotherapy with alpha-particle emitting radionuclides 2004 45 53 83%
MIRD Pamphlet No. 22 (Abridged): Radiobiology and Dosimetry of alpha-Particle Emitters for Targeted Radionuclide Therapy 2010 39 92 40%
Production of [At-211]-Astatinated Radiopharmaceuticals and Applications in Targeted alpha-Particle Therapy 2013 3 99 83%
Advancements in cancer therapy with alpha-emitters: A review 2001 49 27 78%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 RADIOIMMUNE INORGAN CHEM SECT 16 30% 5.0% 47
2 CYCLOTRON PET UNIT 9 64% 1.0% 9
3 CERO 4 75% 0.3% 3
4 INORGAN RADIOIMMUNE CHEM SECT 3 100% 0.3% 3
5 ROB 3 37% 0.8% 7
6 SCI DHAR EL MEHRAZ 3 18% 1.4% 13
7 NANTES ANGERS CANC CRCNA 2 67% 0.2% 2
8 UMR CNRS ICMV 6226 2 67% 0.2% 2
9 RMN HAUTE OLUT 2 29% 0.5% 5
10 CARST 2 33% 0.4% 4

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000205626 EGF DEXTRAN//ANTIBODY BINDING PARAMETERS//BIOMED RADIAT SCI
2 0.0000204886 RADIOIMMUNOTHERAPY//PRETARGETING//Y 90 IBRITUMOMAB TIUXETAN
3 0.0000181136 AUGER ELECTRONS//AUGER ELECTRON EMITTER//CELLULAR DOSIMETRY
4 0.0000098122 ANTIBODY IMMUNOCONJUGATES AND RADIOPHARMACEUTICALS//RADIOIMMUNOGUIDED SURGERY//IMMUNOSCINTIGRAPHY
5 0.0000092191 MELANOMA IMAGING//IMAGERIE MOL THER IE VECTORISEE//MELANOMA TARGETING
6 0.0000091777 RHENIUM 186 HEDP//BONE PAIN PALLIATION//STRONTIUM 89
7 0.0000088093 EXCITATION FUNCTIONS//INTEGRAL YIELD//DEUTERON IRRADIATION
8 0.0000056168 AFFIBODY MOLECULE//AFFIBODY MOLECULES//AFFIBODY
9 0.0000053880 GE 68 GA 68 GENERATOR//GALLIUM 68//GA 68
10 0.0000045959 LEAD FREE BRONZE//COMPOUND SEPARATION METHOD//BIPP